Beste apotheek van Nederland

Saie D J, Sills E S. Hyperprolactinemia presenting with
encephalomalacia-associated seizure disorder and infertility: A
novel application for bromocriptine therapy in reproductive
endocrinology. Neuroendocrinol Lett 2005;26(5):533-537.
Salama N. Nocturnal electrobioimpedance volumetric
assessment in diabetic men with erectile dysfunction before and
after tadalafil intake. Int J Impot Res 2004;16(5):441-447.
Salonia A, Rigatti P, Montorsi F. Sildenafil in erectile
dysfunction: a critical review. Curr.Med Res Opin.
2003;19(4):241-262.
Salonia Andrea, Briganti Alberto, Montorsi Piero et al. Safety
and tolerability of oral erectile dysfunction treatments in the
elderly. [References]. Drugs and Aging 2005;22(4):323-338.
Sato Y, Horita H, Adachi H et al. Effect of oral administration
of prostaglandin E1 on erectile dysfunction. Br J Urol
1997;80(5):772-775.
Savoca G, Silvestre G, Belgrano E. Intracavernosal injection
therapy and surgical therapy in diabetic patients with erectile
dysfunction. [Review] [26 refs]. Diabetes, Nutrition &
Metabolism - Clinical & Experimental 2002;15(1):53-57.
Schanz S, Hauswirth U, Ulmer A et al. Prostaglandin E(1) ethyl
ester, a new agent for topical penile therapy. Int J Impot Res
2002;14(4):317-318.
Schimmer A D, Ali V, Stewart A K et al. Male sexual function
after autologous blood or marrow transplantation. Biology of
Blood & Marrow Transplantation 2001;7(5):279-283.
Schmid D M, Schurch B, Hauri D. Sildenafil in the treatment of
sexual dysfunction in spinal cord-injured male patients. Eur
Urol. 2000;38(2):184-193.
Schouman M, Lacroix P, Amer M. Suppression of prostaglandin
E1-induced pain by dilution of the drug with lidocaine before
intracavernous injection. Br J Urol 1992;148(4):1266
Schroder F H, Whelan P, De Reijke T M et al. Metastatic
prostate cancer treated by flutamide versus cyproterone acetate.
Final analysis of the "European Organization for Research and
Treatment of Cancer" (EORTC) Protocol 30892. Eur Urol
2004;45(4):457-464.
Schulman C C, Shen W, Stothard D R et al. Integrated analysis
examining first-dose success, success by dose, and maintenance
of success among men taking tadalafil for erectile dysfunction.
Urology 2004;64(4):783-788.
Schultheiss D, Stief C G. Physiology and pathophysiology of
erection: Consequences for present medical therapy of erectile
dysfunction. Andrologia 1999;31(SUPPL. 1):59-64.
Schultheiss D, Hiltl D M, Meschi M R et al. Pilot study of the
transdermal application of testosterone gel to the penile skin for
the treatment of hypogonadotropic men with erectile
dysfunction. World J Urol 2000;18(6):431-435.
Seftel A D. From aspiration to achievement:
Assessment and noninvasive treatment of erectile
dysfunction in aging men. J Am Geriatr Soc
2005;53(1):119-130.
Segraves R T, Lee J, Stevenson R et al. Tadalafil for
treatment of erectile dysfunction in men on
antidepressants. J Clin Psychopharmacol
2007;27(1):62-66.
Seidman S N, Pesce V C, Roose S P. High-dose
sildenafil citrate for selective serotonin reuptake
inhibitor-associated ejaculatory delay: open clinical
trial. Hillside J Clin Psychiatry 2003;64(6):721-725.
Setter S M, Iltz J L, Fincham J E et al.
Phosphodiesterase 5 inhibitors for erectile
dysfunction. [Review] [75 refs]. Ann Pharmacother
2005;39(7-8):1286-1295.
Sexton W J, Benedict J F, Jarow J P. Comparison of
long-term outcomes of penile prostheses and
intracavernosal injection therapy.[see comment]. Br J
Urol 1998;159(3):811-815.
Shabbir M, Mikhailidis D M, Morgan R J. Erectile
dysfunction: an underdiagnosed condition associated
with multiple risk factors.[comment]. Current Medical
Research & Opinion 2004;20(5):603-606.
Shabsigh R. Testosterone therapy in erectile
dysfunction and hypogonadism. Br J Sex Med
2005;2(6):785-792.
Shabsigh R. Hypogonadism and erectile dysfunction:
The role for testosterone therapy. Int J Impot Res
2003;15(SUPPL. 4):S9-S13.
Shabsigh R, Burnett A L, Eardley I et al. Time from
dosing to sexual intercourse attempts in men taking
tadalafil in clinical trials. BJU Int 2005;96(6):857-863.
Shabsigh R, Katz M, Yan G et al. Cardiovascular
issues in hypogonadism and testosterone therapy.
[Review] [44 refs]. Am J Cardiol 2005;96(12B):67M­
72M.
Shabsigh R, Padma-Nathan H, Gittleman M et al.
Intracavernous alprostadil alfadex (EDEX/VIRIDAL)
is effective and safe in patients with erectile
dysfunction after failing sildenafil (Viagra). Urology
2000;55(4):477-480.
Shamloul R. Management of honeymoon impotence.
Br J Sex Med 2006;3(2):361-366.
Shamloul R, Atteya A, Elnashaar A et al.
Intracavernous sodium nitroprusside (SNP) versus
papaverine/phentolamine in erectile dysfunction: A
comparative study of short- term efficacy and sideeffects.
Br J Sex Med 2005;2(1):117-120.
D-181